Therapeutic targets and investigated treatments for Ataxia-Telangiectasia
Version 2 2024-06-13, 15:26
Version 1 2022-03-21, 08:57
journal contribution
posted on 2024-06-13, 15:26 authored by MF Lavin, AJ Yeo, AW Kijas, E Wolvetang, PD Sly, C Wainwright, K SinclairTherapeutic targets and investigated treatments for Ataxia-Telangiectasia
History
Journal
Expert Opinion on Orphan DrugsVolume
4Pagination
1263-1276Location
London, Eng.ISSN
2167-8707eISSN
2167-8707Language
EnglishPublication classification
C1 Refereed article in a scholarly journalIssue
12Publisher
Taylor & FrancisUsage metrics
Categories
No categories selectedKeywords
Ataxia-telangiectasiaATM proteinATM-DEFICIENT MICECHROMOSOMAL BREAKAGE SYNDROMESclinical trialsDNA-DAMAGELABORATORY FEATURESLife Sciences & Biomedicineliver diseaselung diseaseMITOCHONDRIAL DYSFUNCTIONneurodegenerationNEUROLOGICAL SYMPTOMSNON-HODGKIN-LYMPHOMAoxidative stressOXIDATIVE STRESSPEDIATRIC-PATIENTSPharmacology & PharmacyPLURIPOTENT STEM-CELLSScience & Technologysteroids3204 Immunology3206 Medical biotechnology3214 Pharmacology and pharmaceutical sciences
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC